Remimazolam is a newly approved benzodiazepine characterized by rapid onset, predictable maintenance, fast recovery, and availability of a reversal agent. We describe four cases of patients who received monitored anesthesia care with remimazolam for gynecological day surgery.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9640626 | PMC |
http://dx.doi.org/10.1002/ccr3.6536 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!